# Merck Sharp & Dohme LLC – FDA Inspection, Apr 30, 2019

Source: https://www.keypedia.com/records/fda_inspections/merck-sharp-dohme-llc/205cf7fa-631d-431d-8b6e-4ae49a333149
Source feed: FDA_Inspections

> FDA inspection 1087963 of Merck Sharp & Dohme LLC, April 30, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 58. Form 483 issued. 15 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1087963
- Company Name: Merck Sharp & Dohme LLC
- Inspection Date: 2019-04-30
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Philadelphia District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1275520 - 2025-07-15
- FDA Inspection 1252348 - 2024-12-12
- [FDA Inspection 1229927 - 2024-08-23](https://www.keypedia.com/records/fda_inspections/merck-sharp-dohme-llc/5bded934-b3a4-469f-b2ba-f705b6b783e2)
- FDA Inspection 1155052 - 2021-07-27
- [FDA Inspection 1103540 - 2019-09-20](https://www.keypedia.com/records/fda_inspections/merck-sharp-dohme-llc/dcc1e4ee-5c35-4ce8-85b9-3a8b8e425941)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/anastasia-i-onuorah/d081d002-e4a4-4001-ba06-b71ff9fbf9f7)
- [Company Rep](https://www.keypedia.com/people/kelly-n-kerr/6f9e1ba0-61ca-403d-a337-9efece792c21)

Company: https://www.keypedia.com/companies/merck-sharp-dohme-llc/842c6e25-ee89-453c-a5b0-6b039c187744

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8